Reviewing Research on Cannabis and COVID-19 with Ethan Russo, MD - CannMed 2024 - Innovation & Investment Summit

Dr. Ethan Russo returns to the podcast to help us make sense of the slew of studies and articles claiming cannabis can treat and/or prevent COVID-19 infection.

Dr. Russo is a board-certified neurologist, a psychopharmacology researcher, an author, a lecturer, and a consultant. He is a CannMed 2022 Keynote Presenter, where he will present on Cannabis and Psychiatry. Although Dr. Russo is not a virologist, he is a very accomplished medical cannabis researcher, and he is well-qualified to help us find the signal in all the noise. During the conversation, we discuss:

What role the endocannabinoid system plays in preventing and clearing a viral infection
The different levels of clinical research
The importance of peer review process
The University of Chicago study that claims CBD inhibits SARS-CoV-2 replication
The Oregon University Study that claims cannabinoid acids can prevent covid infection
Animal models showing CBD can calm the cytokine storm
A preprint study claiming CBD primes the innate immune system
Claims that cannabis smokers have a greater risk for COVID-19 infection

Thank You to This Episode’s Sponsor: Project CBD

Founded in 2010, Project CBD is the first and longest-running website dedicated to research and education on the benefits of CBD, and the premier destination for both curious and committed CBD consumers. Often the first to report on cutting-edge health issues, Project CBD reporting reflects a deeper understanding of developments in cannabinoid science and therapeutics.

Learn more at ProjectCBD.com

Additional Resources

Leave a Reply Cancel reply